A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects with Glioblastoma Multiforme

-
Investigator: Nicholas Butowski, MD
Sponsor: AbbVie Inc.

Location(s): United States

Description

This study is evaluating the safety and pharmacokinetics of ABT-414 in subjects with glioblastoma multiforme.